Soltis Investment Advisors LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1802530
ST. GEORGE, UT
Position in NBIX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$310,787
New position
Shares Held
1,844
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#534
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 50%
Shared 0%
None 50%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $6,186,922 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
81,772 | $5,876,135 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,844 | $310,787 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,787 | 1,844 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||